2022 INTERNATIONAL MEETING ON ASTHMA, RHINITIS, COPD AND THEIR COMORBIDITIES 21-22 NOVEMBER 2022 FIRENZE


MONDAY 21 November 2022


NON ECM PLENARY SESSIONS

RIUNIONE DEI GRUPPI DI LAVORO DEI PROGETTI GOLD E MULTIMORBIDITA’

09:00-13:00 GOLD (COPD) + MULTIMORBIDITY
Chairmen Raffaele F. Antonelli Incalzi, Enrico M. Clini, Lorenzo Corbetta, Dario Manfellotto and Alberto Papi

09:00 Ian D. Pavord
COPD, ASTHMA, CONCOMITANT COPD AND ASTHMA, OR CHRONIC RESPIRATORY DISEASE?

09:40 Bartolome Celli
NEED FOR A NEW DEFINITION OF COPD?

10:20 Claus F. Vogelmeier
MANAGEMENT OF COMORBIDITIES OF COPD AT STABLE STATE AND DURING EXACERBATIONS

11:00 Gerard J. Criner
UPDATE ON NON-PHARMACOLOGIC MANAGEMENT OF COPD: MECHANICAL VENTILATION AND INTERVENTIONAL ENDOSCOPY (EG RHEOPLASTIC)


11:15-11:45 OPEN COFFEE Hotel Lobby


11:40-13:00 BREAKING NEWS IN COPD/MULTIMORBIDITY
FROM THE GOLD 2023 DOCUMENT:
2022 GOLD INTERNATIONAL COPD CONFERENCE SATELLITE SYMPOSIUM

Session devoted to the discussion of updates reported in the document “Global Initiative on bstructive Lung Disease 2023”, published on November 16, during the 2022 GOLD International Conference held in Philadelphia.
Chairman Leonardo M. Fabbri
Speaker Alberto Papi

11:40-11:55 SUMMARY OF THE MOST SIGNIFICANT UPDATES OF THE GOLD 2023 DOCUMENT

11:55-13:00 DISCUSSION


13:00-14:00 LUNCH Hotel Restaurants Arno and Fiesole


14:00-16:00 COLLABORATION BETWEEN ACADEMIC SCIENTISTS AND PHARMA INDUSTRY SCIENTISTS IN THE DEVELOPMENT OF NOVEL TREATMENTS FOR ASTHMA, ALLERGY/RHINITIS, COPD, MULTIMORBIDITY: PANEL DISCUSSION
Conductors Leonardo M. Fabbri, Pierluigi Paggiaro, Alberto Papi and Giovanni Passalacqua

RISK REDUCTION STRATEGIES IN COPD BEYOND INHALED CORTICOSTEROIDS
David A. Lipson
Vice President, Respiratory Disease Area Lead
GLAXOSMITHKLINE

TRANSFORMING HEALTHCARE IN RESPIRATORY
Maria Belvisi
SVP, Early Research and Development, Respiratory & Immunology
Biopharmaceuticals R&D
ASTRAZENECA

RESPIRATORY R&D AT CHIESI: TOWARDS PRECISION MEDICINE
Thomas Eichholtz
Head of Global R&D
CHIESI FARMACEUTICI

THE EFFECTS OF TYPE 2 INFLAMMATION ON NEUROIMMUNE FUNCTION
Rahin Ebrahimzadeh
Global Medical Type 2 Associate Director
Global Divisions Biologics
SANOFI


ECM PLENARY SESSIONS

16:00-17:15 MULTIPLE TREATMENT OF SEVERE COPD AND COMORBIDITIES
Chairmen Raffaele Antonelli Incalzi, Alfredo Chetta and Manuel G. Cosio

Alvar Agusti
TREATABLE TRAITS APPROACH TO THE MANAGEMENT OF CHRONIC RESPIRATORY DISEASES

Klaus F. Rabe
BIOLOGICS IN COPD

Lowie E.G.W. Vanfleteren
HOLISTIC MANAGEMENT OF SEVERE COPD AND COMORBIDITIES


17:15-17:45 COFFEE BREAK Hotel Lobby


17:45-19:00 COPD PHENOTYPES
Chairpersons Sergio A. Harari, Paolo Palange and Marina Saetta

John Hurst
THE BRONCHIECTASIS-COPD PHENOTYPE

Marc Humbert
THE COPD-PULMONARY HYPERTENSION PHENOTYPE

Andrea S. Gershon
COPD WITH HISTORY OF ASTHMA: IS IT A DISTINCT PHENOTYPE?


19:00-19:30 PLENARY LECTURE
Chairmen Eugenio Baraldi, Marco Confalonieri and Diego G. Peroni

Andrew Bush
DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD)



TUESDAY 22 November 2022


ECM PLENARY SESSION

08:00-08:50 PLENARY LECTURES
Chairmen Matteo Bonini, Leonardo M. Fabbri

Monica Kraft
SMALL AIRWAYS IN ASTHMA: THE ATLANTIS STUDY

Monica Kraft
THERMOPLASTY


NON ECM PLENARY SESSION

RIUNIONE DEL GRUPPO DI LAVORO DEL PROGETTO ARIA

08:50-11.30 ARIA (Rinite)
Chairmen Giovanni Passalacqua, Carlo Lombardi, Vincenzo Patella and Antonio Spanevello

08:50 Charles R.W. Beasley
THE NEW ZEALAND ASTHMA GUIDELINES-SIMILARITIES/DIFFERENCES WITH ARIA/GINA

09:15 Lorenzo Cosmi
PATHOPHYSIOLOGY OF CHRONIC SINUSITIS WITH NASAL POLYPS

09:40 Claus Bachert
MANAGEMENT OF CHRONIC SINUSITIS WITH NASAL POLYPS

10:05-11:30 GROUP DISCUSSION: BREAKING NEWS IN ARIA


11:00-11:30 OPEN COFFEE Hotel Lobby


NON ECM PLENARY SESSION

RIUNIONE DEL GRUPPO DI LAVORO DEL PROGETTO GINA

11:30-13:30 GINA (Asma)
Chairpersons Pierluigi Paggiaro, Bianca Beghè, Sergio Bonini and Gianenrico Senna

11:30 Helen K. Reddel
2022 UPDATE OF THE GINA DOCUMENT

11:55 Marteen van den Berge
RATIONALE OF SMART APPROACH IN ASTHMA AND COPD

12:20 Alberto Papi
MANAGEMENT OF MODERATE TO SEVERE ASTHMA: SMART VS NON-SMART

12:20-13:30 GROUP DISCUSSION: BREAKING NEWS IN GINA


13:30-14:30 LUNCH Hotel Restaurants Arno and Fiesole


ECM PLENARY SESSIONS

14:30-15:30 TREATMENT OF DIFFICULT TO CONTROL ASTHMA
Chairmen Nunzio Crimi, Alberto Papi and Adriano Vaghi

Paolo Spagnolo
MACROLIDE IN CHRONIC RESPIRATORY DISEASES

Fabio Luigi Massimo Ricciardolo
MANAGEMENT OF T2 LOW ASTHMA

15:30-16:00 PLENARY LECTURE
Chairmen Eugenio Baraldi, Dario Olivieri and Giovanni Passalacqua

William W. Busse
MICROBIOME AND ASTHMA EXACERBATIONS


16:00-16:30 CME QUESTIONNAIRE AND FAREWELL